Weighted Average Number of Shares Outstanding, Diluted of Niagen Bioscience, Inc. from 03 Jul 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Niagen Bioscience, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 03 Jul 2010 to 31 Dec 2025.
  • Niagen Bioscience, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 85,436,000, a 9.4% increase year-over-year.
  • Niagen Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 85,436,000, a 9.4% increase from 2024.
  • Niagen Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 78,125,000, a 4.2% increase from 2023.
  • Niagen Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 74,985,000, a 7.5% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Niagen Bioscience, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 85,436,000 +7,311,000 +9.4% 01 Oct 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q3 2025 86,619,000 +8,851,000 +11% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 86,241,000 +10,682,000 +14% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 83,232,000 +8,002,000 +11% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 78,125,000 +3,140,000 +4.2% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q3 2024 77,768,000 +2,718,000 +3.6% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 75,559,000 +592,000 +0.79% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 75,230,000 +434,000 +0.58% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 74,985,000 +5,256,000 +7.5% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 75,050,000 +6,705,000 +9.8% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 74,967,000 +6,631,000 +9.7% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 74,796,000 +6,482,000 +9.5% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 69,729,000 +2,544,000 +3.8% 01 Oct 2022 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 68,345,000 +109,000 +0.16% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 68,336,000 +350,000 +0.52% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 68,314,000 +4,150,000 +6.5% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 67,185,000 01 Oct 2021 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q3 2021 68,236,000 +6,541,000 +11% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 67,986,000 +7,080,000 +12% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 64,164,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q3 2020 61,695,000 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 60,906,000 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q2
Q3 2018 55,068,000 +55,020,443 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q4 2017 51,178,664 +13,274,130 +35% 01 Oct 2017 30 Dec 2017 10-K 15 Mar 2018 2017 FY
Q3 2017 47,557* -37,821,115 02 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 42,121,150 +5,131,118 +14% 02 Apr 2017 01 Jul 2017 10-K 15 Mar 2018 2017 FY
Q1 2017 38,030,688 +558,109 +1.5% 01 Jan 2017 01 Apr 2017 10-K 15 Mar 2018 2017 FY
Q4 2016 37,904,534 02 Oct 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 37,868,672 03 Jul 2016 01 Oct 2016 10-K 15 Mar 2018 2017 FY
Q2 2016 36,990,032 +1,186,734 +3.3% 03 Apr 2016 02 Jul 2016 10-K 15 Mar 2018 2017 FY
Q1 2016 37,472,579 +1,739,713 +4.9% 03 Jan 2016 02 Apr 2016 10-K 15 Mar 2018 2017 FY
Q2 2015 35,803,298 05 Apr 2015 04 Jul 2015 10-Q 11 Aug 2016 2016 Q2
Q1 2015 35,732,866 03 Jan 2015 04 Apr 2015 10-Q 12 May 2016 2016 Q1
Q2 2013 99,833,963 +8,471,299 +9.3% 31 Mar 2013 29 Jun 2013 10-Q 13 Aug 2013 2013 Q2
Q1 2013 97,924,457 +13,218,261 +16% 30 Dec 2012 30 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 95,989,122 +20,004,396 +26% 30 Sep 2012 29 Dec 2012 10-K 27 Mar 2014 2013 FY
Q3 2012 98,358,485 +20,058,687 +26% 01 Jul 2012 29 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 91,362,664 +11,828,219 +15% 01 Apr 2012 30 Jun 2012 10-Q 13 Aug 2013 2013 Q2
Q1 2012 84,706,196 +21,761,898 +35% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q4 2011 75,984,726 02 Oct 2011 31 Dec 2011 10-K 29 Mar 2013 2012 FY
Q3 2011 78,299,798 +18,181,615 +30% 03 Jul 2011 01 Oct 2011 10-Q 08 Nov 2012 2012 Q3
Q2 2011 79,534,445 +35,911,042 +82% 03 Apr 2011 02 Jul 2011 10-Q/A 10 Aug 2012 2012 Q2
Q1 2011 62,944,298 03 Jan 2011 02 Apr 2011 10-Q 10 May 2012 2012 Q1
Q3 2010 60,118,183 03 Jul 2010 02 Oct 2010 10-Q 10 Nov 2011 2011 Q3
Q2 2010 43,623,403 04 Apr 2010 03 Jul 2010 10-Q 11 Aug 2011 2011 Q2

Niagen Bioscience, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 85,436,000 +7,311,000 +9.4% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 78,125,000 +3,140,000 +4.2% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 74,985,000 +5,256,000 +7.5% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 69,729,000 +2,544,000 +3.8% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024 2023 FY
2021 67,185,000 +6,118,000 +10% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2023 2022 FY
2020 61,067,000 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2022 2021 FY
2013 100,593,010 +4,603,888 +4.8% 30 Dec 2012 28 Dec 2013 10-K 27 Mar 2014 2013 FY
2012 95,989,122 +20,004,396 +26% 01 Jan 2012 29 Dec 2012 10-K 27 Mar 2014 2013 FY
2011 75,984,726 +27,732,796 +57% 02 Jan 2011 31 Dec 2011 10-K 29 Mar 2013 2012 FY
2010 48,251,930 03 Jan 2010 01 Jan 2011 10-K 15 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.